Yale Neurologist and Neurobiologist Receives Award for Innovative Research
A Yale University professor, Stephen Strittmatter, M.D., has received an award of $300,000 to support his research into the extent to which axons can rearrange themselves and recover after injuries to the nervous system.
The Memory and Brain Disorders Award was one of five made by The McKnight Endowment Fund for Neuroscience, which is an independent organization funded solely by The McKnight Foundation of Minneapolis, Minn. The award is $100,000 for each of three years.
“Over the last decade, basic research has generated a wealth of knowledge about the brain and nervous system,” said Corey Goodman, president of The McKnight Endowment Fund for Neuroscience, Howard Hughes Investigator and Evan Rauch professor of neuroscience at the University of California, Berkeley. “The time has come to apply our knowledge of the brain to solving the problems of neurological and psychiatric diseases. We created the Memory and Brain Disorders Awards to stimulate innovative approaches that might lead to therapies and cures and bring hope to countless patients and their families.”
The Endowment Fund makes three types of awards each year. In addition to the Memory and Brain Disorders Award, they are the McKnight Technological Innovations in Neuroscience Awards, providing seed money to develop technical inventions to enhance brain research; and the McKnight Scholar Awards, supporting neuroscientists in the early stages of their research careers.
Strittmatter, associate professor of neurology and neurobiology and the Vincent Coates chair in neurology at Yale University School of Medicine received the award for research titled: “Nogo Regulation of Axonal Regeneration and Plasticity.”
Strittmatter is examining the extent to which axons – the wires in the brain – can rearrange themselves and recover after injuries to the nervous system. Earlier studies have suggested that, in the brain and spinal cord, inhibitors keep these axons from recovering and therefore make injuries permanent.
Strittmatter’s laboratory and others discovered a gene and protein called Nogo that inhibits axon growth in tissue culture. More recently, Strittmatter’s group identified a receptor protein that binds Nogo to nerve cell axons. The next step is to develop mice lacking the Nogo receptors to find out whether getting rid of the receptor allows axons to grow back. If so, he says, “then we would have a target to develop a drug.” The research ultimately could become the basis of treatments for disabilities caused by spinal cord injuries, strokes and multiple sclerosis.
“We are honored to have such distinguished scientists as the first recipients of the McKnight Memory and Brain Disorders Award,” says Larry Squire, chair of the committee that selected the awardees and a professor of psychology at the University of California, San Diego, School of Medicine. “We look forward to seeing the fruits of their work.”
The McKnight Foundation has supported neuroscience research since 1977. The foundation established the Endowment Fund in 1986 to carry out one of the intentions of founder William L. McKnight (1887-1979). One of the early leaders of the 3M Company, he had a personal interest in memory and its diseases and wanted part of his legacy used to help find cures.
The Endowment Fund’s board members are eminent scientists in the field. Past president Torsten Wiesel and past board member Eric Kandel, for example, are Nobel Prize recipients.
Media Contact
Office of Public Affairs & Communications: opac@yale.edu, 203-432-1345